A

Arcellx Inc
NASDAQ:ACLX

Watchlist Manager
Arcellx Inc
NASDAQ:ACLX
Watchlist
Price: 90.44 USD 3.69% Market Closed
Market Cap: 4.9B USD
Have any thoughts about
Arcellx Inc?
Write Note

Relative Value

The Relative Value of one ACLX stock under the Base Case scenario is 43.51 USD. Compared to the current market price of 90.44 USD, Arcellx Inc is Overvalued by 52%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ACLX Relative Value
Base Case
43.51 USD
Overvaluation 52%
Relative Value
Price
A
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
22
vs Industry
29
Median 3Y
21.7
Median 5Y
21.7
Industry
7.7
Forward
36.9
vs History
vs Industry
Median 3Y
-10.2
Median 5Y
-10.2
Industry
22.7
Forward
-59.2
vs History
0
vs Industry
11
Median 3Y
-5.6
Median 5Y
-5.6
Industry
21.6
vs History
vs Industry
8
Median 3Y
-8
Median 5Y
-8
Industry
25.2
vs History
0
vs Industry
13
Median 3Y
6
Median 5Y
6
Industry
2.5
vs History
17
vs Industry
27
Median 3Y
18.2
Median 5Y
18.2
Industry
7.7
Forward
32.6
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9
vs History
vs Industry
Median 3Y
-7.7
Median 5Y
-7.7
Industry
4.2
Forward
-40.4
vs History
vs Industry
Median 3Y
-7.5
Median 5Y
-7.5
Industry
4.1
Forward
-39.2
vs History
0
vs Industry
12
Median 3Y
-2.9
Median 5Y
-2.9
Industry
5.7
vs History
0
vs Industry
9
Median 3Y
-2.7
Median 5Y
-2.7
Industry
3.6
vs History
0
vs Industry
18
Median 3Y
11.8
Median 5Y
11.8
Industry
4.6

Multiples Across Competitors

ACLX Competitors Multiples
Arcellx Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Arcellx Inc
NASDAQ:ACLX
4.9B USD 31.3 -120.8 -66.3 -62.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 888 840.5 -180 080 -218 674.5 -216 179.2
US
Abbvie Inc
NYSE:ABBV
314.7B USD 5.7 61.9 15.4 23.7
US
Amgen Inc
NASDAQ:AMGN
157B USD 4.8 37.1 17.4 32.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.2B USD 4 890.3 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 859.4 -474.5 -516.7 -502.9
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 6 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.9 -54.9 -59 -53.2
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.6 -130.6 -105.1 -76.6
P/E Multiple
Earnings Growth
US
A
Arcellx Inc
NASDAQ:ACLX
Average P/E: 208
Negative Multiple: -120.8
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 080 N/A
US
Abbvie Inc
NYSE:ABBV
61.9
412%
US
Amgen Inc
NASDAQ:AMGN
37.1
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
890.3
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -474.5 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.9 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -130.6 N/A
EV/EBITDA Multiple
EBITDA Growth
US
A
Arcellx Inc
NASDAQ:ACLX
Average EV/EBITDA: 17.2
Negative Multiple: -66.3
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -218 674.5 N/A
US
Abbvie Inc
NYSE:ABBV
15.4
28%
US
Amgen Inc
NASDAQ:AMGN
17.4
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
38%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -516.7 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -105.1 N/A
EV/EBIT Multiple
EBIT Growth
US
A
Arcellx Inc
NASDAQ:ACLX
Average EV/EBIT: 22.5
Negative Multiple: -62.4
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 179.2 N/A
US
Abbvie Inc
NYSE:ABBV
23.7
88%
US
Amgen Inc
NASDAQ:AMGN
32.9
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -502.9 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.6 N/A

See Also

Discover More
Back to Top